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Abstract D-Aspartate increases human chorionic gonadotropin-
induced testosterone production in purified rat Leydig cells.
L-Aspartate, D-,L-glutamate or D-,L-asparagine could not sub-
stitute for D-aspartate and this effect was independent of
glutamate receptor activation. Testosterone production was
enhanced only in cells cultured with D-aspartate for more than
3 h. The increased production of testosterone was well correlated
with the amounts of D-aspartate incorporated into the Leydig
cells, and L-cysteine sulfinic acid, an inhibitor of D-aspartate
uptake, suppressed both testosterone production and intracellular
D-aspartate levels. D-Aspartate therefore is presumably taken up
into cells to increase steroidogenesis. Intracellular D-aspartate
probably acts on cholesterol translocation into the inner
mitochondrial membrane, the rate-limiting process in steroido-
genesis.
z 1999 Federation of European Biochemical Societies.
Key words: D-Aspartate; Testosterone; Steroidogenesis ;
Leydig cell ; Human chorionic gonadotropin; Glutamate
transporter
1. Introduction
A variety of D-amino acids have been found in the mam-
malian body and widespread and transient appearance of D-
aspartate (D-Asp) has been observed in various mammalian
tissues [1,2]. D-Asp levels transiently increase during the devel-
opment of human [3] and rat brains [4], the rat retina and the
chicken embryonic brain [5]. In the brain of patients with
Alzheimer disease, D-Asp levels are signi¢cantly decreased
[6]. D-Asp is also found in a variety of neuroendocrine and
endocrine organs such as the testis [7,8], pineal [9,10], adrenal
and pituitary glands [4,8] and the time periods of maximal D-
Asp content correspond well with the morphological and
functional maturation of these organs. Immunohistochemical
studies with anti-D-Asp antiserum previously prepared in this
laboratory demonstrated that D-Asp appears and becomes
localized in speci¢c cell types of these organs at distinct peri-
ods of development [7,11,12]. In the di¡erentiating neurons of
the rat central nervous system D-Asp appears to change its
intracellular localization during neurogenesis [13]. In the rat
brain, D-Asp has a⁄nity for the glutamate (Glu) binding site
of NMDA receptors [1], the activation of which is conceivably
involved in ontogeny of the brain [14]. Our recent study in-
dicated that D-Asp is actually synthesized in mammalian cells
[15]. These lines of evidence suggested that D-Asp has some
physiological role as a novel type of messenger in mammals.
We demonstrated in other recent reports that high contents of
D-Asp (as high as 30^40% of total Asp) are present in the
cytoplasm of pinealocytes of the rat pineal gland [9^11].
Although synthesis of D-Asp is minimal to non-existent in
cultured rat pinealocytes, exogenous D-Asp is e⁄ciently taken
up into these cells [16] and released in response to norepi-
nephrine stimulation. This results in the concomitant suppres-
sion of norepinephrine-induced melatonin secretion, presum-
ably via D-Asp stimulation of Glu receptors [16].
In adult rat testis, approximately 30% of total Asp is in the
D-form [7,8]. The D-Asp content is relatively low in the testis
of 3 weeks old rats, but increases between the age of 6 and 10
weeks and then remains constant until the age of 40 weeks [7].
D-Asp is localized in a region rich in elongate spermatids, the
most mature form of germ cells [7]. In isolated rat testis, D-
Asp was suggested to be involved in testosterone synthesis
using a crude mixture of testicular cells [17]. As a further
step towards clarifying the functional signi¢cance of D-Asp
in steroidogenesis, we have puri¢ed Leydig cells from rat testis
and studied the direct e¡ects of D-Asp on human chorionic
gonadotropin (hCG)-stimulated steroidogenesis.
2. Materials and methods
2.1. Animals and reagents
Adult male Sprague-Dawley rats (10^12 weeks old) were purchased
from Charles River Japan (Kanagawa, Japan). Collagenase (type II),
testosterone, BSA, hCG, L-cysteine sul¢nic acid (LCSA), 22(R)-hy-
droxycholesterol, dibutyryl cAMP, D-Asp and other amino acids
were obtained from Sigma (St. Louis, MO, USA). Glu receptor ago-
nists, AMPA, NMDA and quisqualate were from Sigma, kainate
from Wako (Osaka, Japan), DCG-IV and L-AP4 were from Tocris
Cookson (Ballwin, MO, USA). HEPES was from Nacalai Tesque
(Kyoto, Japan). Dulbecco’s modi¢ed Eagle’s medium:F-12 (1:1)
(DMEM/F-12), Medium 199 (M199), penicillin and streptomycin
were purchased from Gibco-BRL (New York, USA). Percoll was a
product of Pharmacia (Uppsala, Sweden). 4-Fluoro-7-nitro-2,1,3-ben-
zoxadiazole (NBD-F) was from Wako. Pirkle-type chiral column,
OA2500(S), was kindly donated by Sumika Chemical Analysis Service
(Osaka, Japan). Rabbit antiserum for testosterone-3(E)-carboxy-
methyloxime-BSA conjugate and testosterone-3(E)-carboxymethyl-
oxime-peroxidase conjugate were obtained from Cosmo Bio (Tokyo,
Japan). Microplates coated with goat antiserum raised against rabbit
IgG were from Eiken Chemical (Tokyo, Japan).
2.2. Preparation of Leydig cells
Puri¢cation of rat Leydig cells was carried out according to the
method of Sun et al. [18] with some modi¢cations. Two decapsulated
rat testes were dispersed by shaking (140^150 cycles/min) for 20 min
at 34‡C in 3 ml of M199-BSA (M199 including 25 mM HEPES, pH
7.3, 0.1% BSA, 100 U/ml penicillin and 100 Wg/ml streptomycin) con-
taining 0.05% collagenase. After incubation, the dispersed tissues were
diluted with M199-BSA and the solution was ¢ltered through a nylon
mesh (Falcon, 70 Wm). Interstitial cells were precipitated by centrifu-
gation of the ¢ltrate and resuspended in 2 ml of M199-BSA. Leydig
cells were puri¢ed on a discontinuous gradient of Percoll in M199-
BSA. The gradient was composed of successive layers of Percoll with
average densities of 1.09, 1.07, 1.05 and 1.035 g/ml. The interstitial
cells were layered on the gradient and centrifuged at 800Ug for
20 min. Cells contained in the layer of Percoll of average density of
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1.07 were then collected, diluted with two volumes of M199-BSA and
centrifuged at 150Ug. Precipitated cells were then washed once and
resuspended in DMEM/F-12-BSA (DMEM/F-12 including 25 mM
HEPES, pH 7.3, 0.1% BSA, 100 U/ml penicillin and 100 Wg/ml strep-
tomycin). Cell viability determined by a trypan blue exclusion test was
more than 90%. The purity of the resulting Leydig cell preparation as
determined by 3L-hydroxysteroid dehydrogenase was more than 85%.
2.3. Leydig cell culture
Puri¢ed Leydig cells were plated in 48-well culture plates (Coster,
Cambridge, MA, USA) and cultured in DMEM/F-12-BSA at 37‡C
under 5% CO2-95% air. The cells were cultured in the presence of
di¡erent concentrations of D-Asp for di¡erent time intervals and
then incubated with hCG (5 mIU/ml) or other compounds for 2 h.
After the incubation, media were collected and centrifuged at 600Ug
for 10 min. The supernatants were stored at 320‡C until assayed for
testosterone. Cell viability was determined by staining the cells with
crystal violet according to the method of Kueng et al. [19] with some
modi¢cations.
2.4. Enzyme immunoassay (EIA) of testosterone
Amounts of testosterone in culture media were measured by EIA
following the method of Marcus and Durnford [20] with some mod-
i¢cations. Intraassay and interassay variations were 8.3% and 11.3%,
respectively.
2.5. Amino acid analysis
Samples for amino acid analysis were prepared by following the
method described in our previous reports [7,10,16]. The wells were
washed with PBS(3) and 10 volumes of methanol were added for
the extraction of cellular amino acids. The amino acids extracted
were then quantitated £uorometrically by HPLC.
2.6. Statistic analysis
Results are expressed as mean þ S.D. Signi¢cant di¡erences between
groups were determined by Duncan’s multiple range test.
3. Results
3.1. Speci¢c stimulation of testosterone synthesis by D-Asp in
rat Leydig cells
In puri¢ed rat Leydig cells, D-Asp directly increased hCG-
induced testosterone synthesis. When puri¢ed rat Leydig cells
were precultured overnight (21 h) in the presence of D-Asp,
hCG-induced testosterone synthesis during the subsequent 2 h
incubation increased approximately four fold compared to
control cells, cultured in the absence of D-Asp (Fig. 1). An
increase in testosterone synthesis was dependent upon the
culture period with D-Asp. After 1 h of culturing with D-
Asp, testosterone synthesis was not yet enhanced, but after
3 h of culturing with D-Asp, testosterone synthesis was con-
siderably stimulated (Fig. 1). As described previously [21],
longer culturing of cells with D-Asp resulted in decreased tes-
tosterone synthesis (Fig. 1), though freshly isolated and puri-
¢ed Leydig cells showed high levels of testosterone synthesis
in response to hCG induction. This may have been due to
decreased hCG sensitivity brought about by longer culturing,
perhaps caused by a decrease in receptor number and/or sig-
nal transduction, since the basal synthetic rate of testosterone
(without induction by hCG) was similar between 1 h and
overnight cultures (1 h: 0.25 þ 0.01 ng/105 cells/h, overnight:
0.24 þ 0.02 ng/105 cells/h). However, the increased synthesis of
testosterone by D-Asp was not ascribable to preserved sensi-
tivity to hCG in the cells, since cAMP content after hCG
challenge was the same between the cultures with and without
D-Asp (data not shown). In addition, crystal violet staining
demonstrated that numbers of cells attached to the wells were
almost the same after preculturing in the presence or absence
of D-Asp (the absorbance of the stained cells precultured with
D-Asp was 117% compared to that without D-Asp). These
results indicated that culturing with exogenous D-Asp in-
creases hCG-induced testosterone production in rat Leydig
cells after more than 3 h. In the following experiments the
cells were precultured with D-Asp for 16 h, since this resulted
in the highest increase in testosterone production compared to
control cells.
D-Asp is known to act as an agonist for Glu receptors [1].
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Fig. 1. Time-dependent increase of testosterone synthesis by D-Asp
in rat Leydig cells. Puri¢ed Leydig cells were cultured for the indi-
cated time periods in the presence or absence (control) of 200 WM
of D-Asp. The control medium (without addition of D-Asp) con-
tained approximately 25 nM of D-Asp. Subsequently the cells were
incubated in the medium containing 5 mIU/ml of hCG for 2 h and
testosterone in the medium was assayed by EIA. An increase in tes-
tosterone synthesis was observed at similar levels in the cultures for
16 h up to 24 h. Signi¢cantly di¡erent compared to control,
*P6 0.05, n = 3; **P6 0.01, n = 3.
Table 1
Stereospeci¢city of D-Asp stimulation of testosterone synthesis in rat
Leydig cells
Testosterone (ng/105 cells/h)
Experiment I
Control 6.7 þ 0.6
D-Aspartate 19.6 þ 2.2**
L-Aspartate 7.7 þ 0.3
D-Glutamate 7.3 þ 0.9
L-Glutamate 6.4 þ 1.0
Experiment II
Control 5.9 þ 0.3
AMPA 7.8 þ 0.4
NMDA 6.0 þ 0.5
Kainate 6.6 þ 0.4
Experiment III
Control 6.5 þ 0.3
Quisqualate 8.5 þ 1.2
DCG-IV 8.9 þ 1.4
L-AP4 5.0 þ 0.3
Puri¢ed rat Leydig cells were precultured with various compounds as
indicated (200 WM each) for 16 h. Subsequent incubation with hCG
and assay of testosterone were the same as in Fig. 1. 500 WM of
synthetic agonists were also examined with similar results. Agonists
for ionotropic Glu receptors and metabotropic Glu receptors were
assayed in Exp. II and Exp. III, respectively. Signi¢cantly di¡erent
compared to control: **P6 0.01, n = 3.
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Our previous report suggested that activation of the receptor
by D-Asp is involved in the suppression of melatonin secretion
in rat pineal gland [16]. Therefore D-Asp also may participate
in the increased synthesis of testosterone in rat Leydig cells
through activation of the receptors. However, this is not the
case. L-Asp, D-,L-Glu (Table 1), D- or L-asparagine (data not
shown) could not substitute for D-Asp and various synthetic
agonists for the subtypes of Glu receptors were not e¡ective as
a substitute for D-Asp. Furthermore, the stimulation by D-Asp
was not a¡ected in the presence of these receptor agonists or
antagonists (data not shown). These results indicated that the
increase in testosterone production by D-Asp is independent
of activation of Glu receptors in rat Leydig cells.
3.2. Uptake of D-Asp in rat Leydig cells
In the following studies we addressed the issue of whether
prior incorporation of D-Asp into the Leydig cells and subse-
quent culturing are necessary for the increase in testosterone
production. Fig. 2 indicates that the amounts of testosterone
produced were dependent on the doses of exogenous D-Asp.
The amounts of D-Asp taken up into the cells also increased
depending on the doses of D-Asp and its amounts in the cells
were well correlated with the amounts of testosterone synthe-
sized (Fig. 2). D-Asp was presumably incorporated into the
cells via the L-Glu transporter which has an a⁄nity for D-Asp
in addition to L-Glu and L-Asp [22,23]. D-Asp accumulated at
a high level in the cells probably due to a very low level of
degradation by D-Asp-oxidase in the testis [24]. Our prelimi-
nary experiments performed with RT-PCR revealed that a
major subtype of Glu transporters expressed in rat Leydig
cells is GLAST [25], which is e⁄ciently inhibited by LCSA
[26]. As demonstrated in Fig. 3, D-Asp incorporation into the
cells and stimulation of testosterone production by D-Asp
were concomitantly suppressed depending on the doses of
LCSA. D-Asp content in the cells was again well correlated
with testosterone production. LCSA itself had almost no ef-
fects on the production of testosterone without D-Asp,
although it brought about a weak increase in testosterone
synthesis at some doses (Fig. 3).
The decrease in the cellular content of D-Asp and the drop
in testosterone production elicited by LCSA were both re-
stored by the simultaneous addition of a higher dose of D-
Asp (in cells precultured with 200 WM of D-Asp, the cellular
content of D-Asp and testosterone production were suppressed
by 50 WM LCSA to 50% and 60%, respectively, but could be
completely restored by the addition of 400 WM D-Asp). It is
interesting that when the cells were cultured without D-Asp
for 24 h prior to culturing with D-Asp for 16 h, testosterone
synthesis no longer increased, though basal testosterone pro-
duction remained constant after 24 h of culture. Uptake of D-
Asp also signi¢cantly decreased in these cells precultured for
24 h. These lines of evidence suggested that D-Asp must be
taken up into fresh Leydig cells for the stimulation of testos-
terone production.
3.3. D-Asp e¡ect on the testosterone synthetic pathway
In response to hCG stimulation, receptor-coupled adenylate
cyclase is activated [27] and increased levels of cAMP stimu-
late testosterone production by an unde¢ned mechanism in
Leydig cells [28^30]. Therefore, dibutyryl cAMP can substi-
tute for hCG in the induction of testosterone synthesis. Fig. 4
indicates that D-Asp increased dibutyryl cAMP-induced tes-
tosterone synthesis similarly to hCG. As described above,
cAMP contents after hCG challenge were not a¡ected by
preculturing the cells with D-Asp. These results suggested
that the e¡ect of D-Asp on testosterone synthesis is beyond
cAMP formation.
The ¢rst step of testosterone synthesis is the conversion of
cholesterol to pregnenolone, which is catalyzed by P-450 side-
chain cleavage (P-450scc) in inner mitochondrial membranes
[28^30]. The overall rate of testosterone synthesis is limited by
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Fig. 2. E¡ect of various doses of D-Asp on testosterone synthesis
and D-Asp contents in Leydig cells. Puri¢ed Leydig cells were cul-
tured with the indicated doses of D-Asp for 16 h. Subsequently the
cells were incubated in the medium containing 5 mIU/ml of hCG
for 2 h as in Fig. 1. Testosterone in the medium and cellular D-Asp
content after culturing for 16 h were determined (n = 3) as in Sec-
tion 2. The increase of testosterone production was also observed in
a range of hCG concentrations from 0.2 to 125 mIU/ml and in a
time period of 5 h after the addition of hCG.
Fig. 3. E¡ect of LCSA on testosterone synthesis and Asp contents
in Leydig cells. Puri¢ed Leydig cells were incubated with indicated
doses of LCSA for 10 min prior to the addition of 200 WM D-Asp
and cultured for 16 h. Control cells received no D-Asp. Subsequent
incubation with hCG and assay of testosterone were the same as in
Fig. 1. The amounts of testosterone synthesized and D-Asp contents
in the cells after 16 h of culturing with D-Asp and LCSA were de-
termined (n = 3) as in Section 2.
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the availability of cholesterol to the intramitochondrial
P-450scc. To surmount this limitation, 22(R)-hydroxycholes-
terol, a freely accessible substrate to the side-chain cleavage
reaction, can be supplied to attain maximal testosterone syn-
thesis by the steroidogenic cascade [31]. In order to investigate
the e¡ect of D-Asp on the ultimate capacity of P-450scc and
subsequent steroidogenic cascade, testosterone synthesis was
measured after supplying 22(R)-hydroxycholesterol to the
cells. As in Fig. 4, similar amounts of testosterone were pro-
duced in control and D-Asp-treated cells in the presence of the
cholesterol derivative, indicating that D-Asp does not a¡ect
the P-450scc and subsequent enzymatic steps. These lines of
evidence imply that the e¡ect of D-Asp is beyond cAMP for-
mation and prior to the side-chain cleavage by P-450scc, pos-
sibly supply of cholesterol to the P-450scc.
4. Discussion
Here we demonstrate that D-Asp increases hCG-induced
testosterone synthesis in puri¢ed rat Leydig cells. This in-
crease in steroidogenesis was speci¢c to D-Asp and the e¡ect
was independent of Glu receptor activation. Increased testos-
terone synthesis was observed only in cells precultured for
more than 3 h with D-Asp. D-Asp is presumably to be taken
up into the cells to increase steroidogenesis.
A recent study performed by our group [16] indicates that
D-Asp taken up into cultured rat pinealocytes is released upon
norepinephrine stimulation and concomitantly suppresses nor-
epinephrine-induced secretion of melatonin. This suppression
was also observed with L-Glu and L-Asp and these agonists
assumed to activate the Glu receptor(s) and subsequently sup-
pressed the activity of arylalkylamine N-acetyltransferase, a
rate-limiting step in melatonin production [32^34]. By con-
trast, the stimulation of testosterone synthesis in rat testis is
speci¢c to D-Asp and independent of Glu receptor activation,
as described in this study. The mechanism for increase of
testosterone synthesis by D-Asp is apparently distinct from
that of melatonin secretion suppression in the pineal gland.
In adult rat testis, the levels of D-Asp are as high as 30^40%
of the total Asp content [7,8]. D-Asp levels show a strong
relation with testosterone content in the testis during develop-
ment [17]. In a crude mixture of rat testicular cells, D-Asp has
been suggested to be involved in testosterone synthesis [17].
The testis consists of various types of cells [35] and testoster-
one synthesis in the testis is under control of autocrine factors
as well as paracrine factors from these cells [36,37]. This study
showed that D-Asp directly increases hCG-induced testoster-
one production in puri¢ed rat Leydig cells. Recently D-Asp
has been reported to suppress testosterone production in iso-
lated ovarian follicles of the green frog Rana esculenta [38]. In
the gonads D-Asp presumably behaves as a paracrine factor
for the regulation of steroidogenesis in spite of di¡erential
e¡ects depending on species and sex.
We demonstrated by immunohistochemical and biochemi-
cal techniques that D-Asp is mainly localized in the cytoplasm
of elongate spermatids, the most mature of the germ cells and
at very low levels in interstitial cells (including Leydig cells)
and Sertoli cells [7]. D-Asp contents in puri¢ed rat Leydig cells
were actually very low (Fig. 2b), although its presence in
Leydig and Sertoli cells has been reported [17]. During the
¢nal steps of germ cell maturation, elongate spermatids expel
most of their cytoplasm and deposit it in the seminiferous
tubules when they are released as free spermatozoa into the
epididymides [39]. Since D-Asp content in the epididymides is
very low compared to that in the testes [7], most of the D-Asp
in the spermatids is assumed to remain in the seminiferous
tubules and regulate steroidogenesis in Leydig cells in the
interstitial spaces in a paracrine fashion.
In Leydig cells, steroidogenic pathways begin in the mito-
chondria with the conversion of cholesterol to pregnenolone
[28^30]. Cholesterol is transported from intracellular sources
(across the outer mitochondrial membrane) to the inner mi-
tochondrial membrane where it is converted to pregnenolone
by P-450scc. Pregnenolone is subsequently converted to tes-
tosterone in the steroidogenic cascade outside the mitochon-
dria. The process of translocation to the inner mitochondrial
membrane is the rate-limiting step for testosterone synthesis,
which is activated in response to hCG stimulation through
increased levels of cAMP. Recent investigations have revealed
several components involved in cholesterol transfer, such as
steroidogenic acute regulatory protein [28] and peripheral-type
benzodiazepine receptor [29], a multiprotein channel that al-
lows the transition of cholesterol. The results described in this
study suggest that D-Asp acts on the process of cholesterol
translocation to the inner mitochondrial membrane. The
mechanisms of cholesterol movement into steroidogenic mito-
chondria are not yet de¢ned and D-Asp may be involved in
this key process of steroidogenesis. Further research on the
mechanism of action of D-Asp should certainly provide val-
uable insight into the functional roles of D-Asp in endocrine
organs.
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